allergy

Landmark study identifies asthma in infantsA Canadian study reveals how clinicians may be able to identify whether asthma will develop in patients as young as age one.
Experts offer top allergy tips
Experts offer top allergy tipsWe asked industry experts for their top suggestions to colleagues on how to best manage allergy.
New therapies needed for allergy symptoms, quality of lifeHalf of patients with ocular allergies report experiencing symptoms year-round. While nearly all of them take eye drops to treat their symptoms, the majority report limited or no effect from over-the-counter drops, according to a new survey. The results suggest that new treatment approaches would improve both symptoms and quality of life.
Top solutions to lower drug pricesPBMs partnering with pharmacies and drug makers may have a solution to nonadherence due to high pharma costs.
Substance P: Dry eye and allergy’s mixed signal or missing link?Inflammation may lead to heightened peripheral sensitization and stimulation through a developing concept in which neuroimmune cross-talk causes the confounding interplay of both signs and symptoms in dry eye and allergic disease.
Topical cetirizine latest therapy to treat allergic conjunctivitisOral cetirizine is one of the most used oral medications for treatment of allergic rhinitis. In May 2017, the FDA approved the first ophthalmic formulation of the second-generation histamine-1 (H1) receptor antagonist for use in treating ocular itching associated with allergic conjunctivitis.
Epicutaneous immunotherapy may transform allergy treatment
Epicutaneous immunotherapy may transform allergy treatmentAs an allergy sufferer myself, I tend to pore over the journals and literature to learn what new exciting technologies may be on the horizon. When I came across epicutaneous immunotherapy (EPIT), my mind went in a multitude of different directions about the endless possibilities for both systemic and ocular allergy management.
The latest ocular allergy treatments worth watchingProgress of ocular allergy treatment in 2017 starts with the fact that this is a mature therapeutic space, with a range of existing choices for clinicians and patients. Progression in therapies from artificial tears to antihistamines and mast cell stabilizers to topical steroids provides a suitable choice for most patients with ocular allergies.
Intracanalicular insert soothes ocular itching in allergic conjunctivitisA phase III study of dexamethasone insert, 0.4 mg (Dextenza, Ocular Therapeutix) found that the sustained-release intracanalicular insert is safe, effective, and well tolerated for treating ocular itching associated with allergic conjunctivitis.
Allergy questionnaire helps determine true penicillin allergy in childrenAlthough penicillin allergy is the most commonly reported medication allergy in children, the true incidence of this allergy in children is low with data suggesting that the large numbers of adverse drug reactions reported by parents as signs of an allergic reaction, such as rash or diarrhea associated with antibiotics, may not be consistent with a true allergic reaction.